Try Alerts Free   |   Login
Health Care › Pharmaceutical Preparations

NeuBase Therapeutics (NBSE) Financials and Smart Investor 13F Alerts

See how revenue, income, cash flow, and balance sheet financials have changed over 36 quarters since 2011. Compare with NBSE stock chart to see long term trends.

NBSE stock compared to

NBSE Income Statement

Research & Development Expense:2019924
Total Operating Expenses:4661394
Operating Income:-4661394
Income Taxes:0
Net Income:-4066431
Earnings Per Share, Basic:-0.18
Shares Outstanding, Basic Avg:23180024

NBSE Cash Flow

Operating Activities Net Income:
Depreciation, Depletion & Amortization:68117
Net Cash from Operations:-3780861
Repurchases/Buybacks Common Stock:null
Net Cash from Financing Activities:-26111
Property, Plant & Equipment Purchases:193571
Net Cash from Investing Activities:-208541
Net Change in Cash & Equivalents:-4015513

NBSE Balance Sheet

Cash and Cash Equivalents:27976770
Total Current Assets:28818159
Property, Plant & Equipment, Net:1292388
Total Assets:30759090
Accounts Payable:1177955
Total Liabilities:2241842

Major Holders (from 13F filings)

Investment Type
Change
Value (x$1000)
increase or decrease
Greenlight Capital Inc
2,027,027 sh
123,800 sh
7%
$15,386
-$1,325
Vanguard Group Inc
916,553 sh
787,965 sh
613%
$6,957
$5,828
Blackrock Inc.
906,303 sh
-26,347 sh
-3%
$6,879
-$1,310
Renaissance Technologies LLC
556,732 sh
-339,346 sh
-38%
$4,226
-$3,642
Northern Trust Corp
194,749 sh
752 sh
0%
$1,478
-$225
Goldman Sachs Group Inc
86,724 sh
72,823 sh
524%
$658
$536
Charles Schwab Investment Management Inc
41,158 sh
-2,314 sh
-5%
$313
-$69
California State Teachers Retirement System
26,031 sh
 
$198
Tocqueville Asset Management L.P.
20,350 sh
20,350 sh
NEW
$154
$154
Bank Of America Corp /De/
20,268 sh
-7,645 sh
-27%
$153
-$92
Oppenheimer & Co Inc
13,800 sh
13,800 sh
NEW
$105
$105
Price T Rowe Associates Inc /Md/
12,342 sh
12,342 sh
NEW
$94
$94
Morgan Stanley
11,672 sh
-3,358 sh
-22%
$89
-$43
Strs Ohio
4,400 sh
 
$33
Legal & General Group Plc
2,171 sh
-675 sh
-24%
$16
-$9
Royal Bank Of Canada
1,800 sh
 
$14
Ameritas Investment Partners, Inc.
1,525 sh
 
$12
Proequities, Inc.
0 sh
 
$0

Data imported from NeuBase Therapeutics, Inc. SEC filings. Check original filings before making any investment decision.